Nov 012024
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Orlynvah | sulopenem etzadroxil, probenecid | 10/25/2024 | To treat uncomplicated urinary tract infections (uUTI) | ||
| Vyloy | zolbetuximab-clzb | 10/18/2024 | To treat gastric or gastroesophageal junction adenocarcinoma | Drug Trials Snapshots: VYLOY | |
| Hympavzi | marstacimab-hncq | 10/11/2024 | To prevent or reduce bleeding episodes related to hemophilia A or B | Press Release | |
| Itovebi | inavolisib | 10/10/2024 | To treat locally advanced or metastatic breast cancer |
Sorry, the comment form is closed at this time.